Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
- López-Díaz de Cerio, A.
- García-Muñoz, R.
- Pena, E.
- Panizo, Á.
- Feliu, J.
- Giraldo, P.
- Rodríguez-Calvillo, M.
- Martínez-Calle, N.
- Grande, C.
- Olave, M.T.
- Andrade-Campos, M.
- Bandrés, E.
- Núñez-Córdoba, J.M.
- Inogés, S.
- Panizo, C.
ISSN: 1365-2141, 0007-1048
Année de publication: 2020
Volumen: 189
Número: 6
Pages: 1064-1073
Type: Article